Skip to main content
. 2018 Jan 23;2:PO.17.00143. doi: 10.1200/PO.17.00143

Fig 1.

Fig 1.

(A) Oncoprint of germline and somatic mutations in mismatch repair (MMR) genes and in POLE in the Lynch cohort. (B) Mutational decomposition analysis of the samples with ≥ 10 somatic mutations. (*) Hypermutated sporadic upper-tract urothelial carcinoma (UTUC) tumor with a hotspot mutation in POLE. (C) Microsatellite instability (MSI) sensor scores across the two cohorts. (D) Frequency of somatic alterations in Lynch syndrome–associated (n = 17) and sporadic UTUC (n = 82) cohorts. AID/APOBEC, activation-induced cytidine deaminase/apolipoprotein B mRNA-editing enzyme catalytic polypeptide; CNV, copy-number variation; DDR, DNA damage repair; NS, non significant; RCC, renal cell carcinoma.